These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


608 related items for PubMed ID: 4404454

  • 1. The in vivo activity of in vitro immunized mouse thymocytes. II. Rejection of skin allografts and graft-vs-host activity.
    Rouse BT, Wagner H.
    J Immunol; 1972 Dec; 109(6):1282-9. PubMed ID: 4404454
    [No Abstract] [Full Text] [Related]

  • 2. Adaptive phenomena in bone marrow transplantation.
    Goujet-Zalc C, Ilbery PL.
    Exp Hematol; 1973 Dec; 1(1):3-10. PubMed ID: 4154047
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Mouse mixed lymphocyte reactions and cell-mediated lympholysis: genetic control and relevance to antigenic strength.
    Abbasi K, Démant P, Festenstein H, Holmes J, Huber B, Rychiková M.
    Transplant Proc; 1973 Dec; 5(4):1329-37. PubMed ID: 4149544
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. In vivo activity of in vitro immunized lymphocytes. I. Tumor allograft rejection mediated by in vitro activated mouse thymocytes.
    Rouse BT, Wagner H, Harris AW.
    J Immunol; 1972 May; 108(5):1353-61. PubMed ID: 4623947
    [No Abstract] [Full Text] [Related]

  • 7. Cell-mediated immune responses in vitro. V. A comparative study of in vitro immunogenicity of splenic lymphocytes, neoplastic lymphoid cells and fibroblats.
    Wagner H, Wyss C.
    Eur J Immunol; 1973 Sep; 3(9):549-55. PubMed ID: 4271926
    [No Abstract] [Full Text] [Related]

  • 8. Physical properties of mouse spleen cells involved in the mixed leukocyte reaction and graft-vs-host disease.
    el-Arini MO, Osoba D.
    J Immunol; 1973 Jun; 110(6):1476-84. PubMed ID: 4145892
    [No Abstract] [Full Text] [Related]

  • 9. Study of the thymic-derived or -independent nature of mouse spleen cells induced to proliferate in culture by various mitogens and antigens.
    Piguet PF, Vassalli P.
    Eur J Immunol; 1973 Aug; 3(8):477-83. PubMed ID: 4585311
    [No Abstract] [Full Text] [Related]

  • 10. Thymus dependence of lymphocyte trapping.
    Zatz MM, Gershon RK.
    J Immunol; 1974 Jan; 112(1):101-6. PubMed ID: 4149589
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Studies on the induction and expression of T cell-mediated immunity. 3. Amplification by papain of the generation of cytotoxic lymphocytes to allogeneic cells.
    Kedar E, Bonavida B.
    J Immunol; 1974 Oct; 113(4):1386-9. PubMed ID: 4153487
    [No Abstract] [Full Text] [Related]

  • 13. Correlation between cellular manifestations of allograft response and graft rejection times.
    Viklický V, Polácková M.
    Folia Biol (Praha); 1974 Oct; 20(2):125-32. PubMed ID: 4140110
    [No Abstract] [Full Text] [Related]

  • 14. Cellular immunology and the pathogenesis of graft versus host reactions.
    Elkins WL.
    Prog Allergy; 1971 Oct; 15():78-187. PubMed ID: 4151282
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Some comments on lymphocyte-mediated cytotoxicity and blocking serum activity in allograft tolerance.
    Hellström I, Hellström KE.
    Johns Hopkins Med J Suppl; 1974 Oct; 3():301-5. PubMed ID: 4607384
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. The influence of graft-versus-host reactivity, lymphocyte depletion, and cell dose on allogeneic bone marrow engraftment.
    Glass B, Uharek L, Gaska T, Gassmann W, Löffler H, Müller-Ruchholtz W.
    Bone Marrow Transplant; 1993 Oct; 12 Suppl 3():S41-7. PubMed ID: 8124257
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 31.